The broader benefits beyond glucose control are increasingly recognised in clinical decision-making, though prescribing decisions should be individualised based on patient characteristics, comorbidities, and treatment goals
Tirzepatide has shown similar results: in a phase 2 trial, up to 73.3% of participants at the highest dose achieved MASH resolution without worsening fibrosis at 52 weeks, compared to 13.2% on placebo
Metabolomics and molecular docking-directed anti-obesity study of the ethanol extract from Gynostemma pentaphyllum (Thunb.) Makino
Ramka regulacyjna status WADA (dwie kategorie) Blend czy dwa peptydy o odmiennej kategorii antydopingowej, ale oba znajduj si na licie zabronionej WADA
Semaglutide GLP-1 suppresses appetite and boosts energy expenditure for sustainable weight loss and better BMI management
Liraglutide is typically administered via subcutaneous injection and is marketed under the brand name Victoza for diabetes treatment and Saxenda for weight management